Skip to main content
. 2015 Jul 20;6(29):28104–28119. doi: 10.18632/oncotarget.4612

Figure 5.

Figure 5

Metastatic burden following injection of 231-WT, 231-EV and 231-HIF shRNA cells through the tail vein. A. Representative images of H&E stained 5 mm thick lung sections acquired at 1X and enlarged. B. Quantitation of metastatic burden (*p < 0.05, #p < 0.08). Values represent Mean ± SE, n = 5 mice for each group.